BNTC – benitec biopharma inc. (US:NASDAQ)
Stock Stats
News
Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference
Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update
Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade [Seeking Alpha]
Benitec Biopharma (NASDAQ:BNTC) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response [Yahoo! Finance]
Form 8-K Benitec Biopharma Inc. For: Feb 12
Form 10-Q Benitec Biopharma Inc. For: Dec 31
Form EFFECT Benitec Biopharma Inc.
Form 424B3 Benitec Biopharma Inc.
Form S-3 Benitec Biopharma Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.